Wegovy Compared to Mounjaro: Understanding the Key Mechanisms
When evaluating Wegovy compared to Mounjaro, the fundamental difference lies in their receptor targeting mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone to reduce appetite and promote satiety after meals. Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors, offering dual incretin action that may provide additional metabolic benefits beyond appetite control.
Both prescription-only medicines work by slowing gastric emptying and influencing brain appetite centres, but their receptor profiles create distinct treatment experiences. The choice between Wegovy and Mounjaro often depends on individual response patterns, lifestyle factors, and clinical considerations that your prescriber will evaluate during consultation. At EverydayMeds, our clinical team helps you understand which mechanism may align better with your weight management goals and medical history.
Wegovy vs Mounjaro Pricing: Complete UK Cost Breakdown
Understanding the financial commitment when comparing Wegovy to Mounjaro helps inform your treatment decision. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles like the Intro Duo (0.25mg & 0.5mg) cost £169.99, providing your first 8 weeks of treatment with convenient delivery scheduling.
New customers can apply code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices. Our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring treatment continuity without repeated ordering. Both Wegovy and Mounjaro require similar dose escalation periods, so comparing total treatment costs over 16-20 weeks provides the most accurate financial picture for your weight management investment.
Clinical Evidence: Wegovy Compared to Mounjaro Trial Results
In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent efficacy across different patient populations, with STEP 2 showing 9.6% weight reduction in patients with type 2 diabetes.
Mounjaro's SURMOUNT trials showed tirzepatide's dual receptor action in weight management contexts, though direct head-to-head comparisons between the treatments use different trial designs and patient populations. Both medications require prescription alongside a reduced-calorie diet and increased physical activity, with individual results varying based on adherence and lifestyle factors that your EverydayMeds prescriber will discuss during assessment.
How Wegovy Works: GLP-1 Receptor Mechanism Explained
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a hormone naturally released by your intestines after eating. This mechanism triggers several appetite-regulating processes: it slows the movement of food from your stomach into your small intestine, creating prolonged feelings of fullness after smaller meals. The medication also acts on appetite control centres in your brain, potentially reducing food cravings and the desire to eat between meals. Weekly injections using the FlexTouch pen maintain consistent semaglutide levels, supporting sustained appetite regulation throughout your treatment. This once-weekly dosing schedule fits easily into most lifestyles, requiring just one injection every seven days at any time that suits your routine.
Ordering Process: 3-Step Wegovy Purchase Journey
Purchasing Wegovy through EverydayMeds follows a streamlined three-step process designed for convenience and safety. First, complete our 3-minute online clinical assessment covering your medical history, current medications, weight management goals, and any relevant health conditions. Next, our qualified prescribers review your assessment within standard 3 working days (or 24 hours with express service), ensuring Wegovy is clinically appropriate for your circumstances. Finally, once approved, your genuine Novo Nordisk Wegovy ships via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit to preserve medication efficacy.
Storage Advantages: Wegovy vs Mounjaro Practical Comparison
Storage requirements present a key practical difference when considering Wegovy compared to Mounjaro for busy lifestyles. Wegovy offers superior travel flexibility with 6 weeks of room temperature storage (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy particularly suitable for frequent travellers, shift workers, or anyone with irregular schedules who might struggle with strict refrigeration requirements. The FlexTouch pen system provides reliable dose delivery with clear dose indicators, while the weekly injection schedule means fewer administration occasions compared to daily medications. Both treatments require initial refrigerated storage at 2-8°C, but Wegovy's extended room temperature tolerance provides additional peace of mind for real-world usage scenarios.
Wegovy Compared to Mounjaro: Choosing Your UK Treatment Path
Deciding between Wegovy and Mounjaro involves weighing clinical evidence, lifestyle factors, and individual treatment responses that vary between patients. Wegovy's established GLP-1 mechanism offers proven weight management support with extensive real-world usage data, whilst Mounjaro's dual receptor approach may appeal to patients seeking broader metabolic effects. Storage convenience, dosing schedules, and side effect profiles differ between treatments, making personalised prescriber guidance essential.
At EverydayMeds, both treatments are available through our GPhC-registered pharmacy (#9012878), ensuring you receive genuine medications regardless of which option suits your needs. Our clinical team evaluates your individual circumstances, medical history, and treatment preferences to recommend the most appropriate option, with the flexibility to switch treatments if your initial choice doesn't provide optimal results.
Start Your Weight Management Journey: Order Wegovy Today
Both Wegovy and Mounjaro are available from EverydayMeds with the same expert clinical support and next-day delivery service. New customers can use code FIRST40 at checkout, while returning customers apply DOSE25 to access our competitive pricing structure. Our clinical assessment takes just 3 minutes to complete, with most patients receiving prescriber approval within 48 hours for immediate treatment commencement. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment and join thousands of patients successfully managing their weight with professional clinical support. Whether you choose Wegovy's proven GLP-1 action or decide Mounjaro's dual mechanism better suits your needs, our qualified team ensures safe, effective treatment from consultation through ongoing care.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026